Trexquant Investment’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Buy
179,887
+146,297
+436% +$3.28M 0.02% 854
2026
Q1
$758K Buy
+33,590
New +$772K 0.01% 1324
2024
Q3
Sell
-42,906
Closed -$819K 1637
2024
Q2
$819K Buy
42,906
+12,885
+43% +$263K 0.01% 1071
2024
Q1
$579K Buy
+30,021
New +$595K 0.01% 1106
2023
Q2
Sell
-36,936
Closed -$785K 1549
2023
Q1
$785K Buy
+36,936
New +$707K 0.02% 820
2022
Q4
Sell
-17,249
Closed -$242K 1480
2022
Q3
$242K Buy
+17,249
New +$326K 0.01% 1116
2022
Q2
Sell
-10,257
Closed -$345K 1620
2022
Q1
$345K Sell
10,257
-4,508
-31% -$148K 0.02% 930
2021
Q4
$479K Buy
+14,765
New +$486K 0.03% 661
2019
Q1
Sell
-19,898
Closed -$644K 1089
2018
Q4
$644K Buy
+19,898
New +$803K 0.04% 549
2018
Q2
Sell
-7,520
Closed -$384K 991
2018
Q1
$384K Buy
+7,520
New +$401K 0.03% 720
2017
Q2
Sell
-8,663
Closed -$365K 901
2017
Q1
$365K Buy
8,663
+3,570
+70% +$148K 0.05% 668
2016
Q4
$215K Buy
+5,093
New +$208K 0.03% 788

Other funds holding FMS

Trexquant Investment's FMS Position: Q2 2026 in Review

Trexquant Investment increased its Fresenius Medical Care (FMS) stake by 436% in Q2 2026, buying an estimated $3.28M and bringing the position to 179,887 shares worth $4.07M. The position accounts for 0.02% of the portfolio, ranked #854.

Trexquant Investment first reported a position in FMS in Q4 2016 and has held it in 12 quarters since. 235 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Trexquant Investment held 179,887 shares of Fresenius Medical Care worth $4.07M as of Q2 2026.
  • Trexquant Investment bought 146,297 Fresenius Medical Care shares in Q2 2026, an estimated $3.28M.
  • Fresenius Medical Care made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #854 holding.
  • Trexquant Investment first reported a position in Fresenius Medical Care in Q4 2016 and has held it in 12 quarters since.
  • 235 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.